Coeptis Therapeutics, Inc. (COEP)
NASDAQ·Healthcare·Biotechnology
$16.62
+0.93%
Mkt Cap $44.73M
No analyst coverage available
We don't have analyst ratings or price target data for Coeptis Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.